A comprehensive view of patent expirations / application cessations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Researchers Submit Patent Application, 'Implant For The Sustained Release Of An Active Ingredient', for Approval (USPTO 20240269445)
Published:
September 02, 2024
by Disease Prevention Daily
|
Fitch Upgrades AstraZeneca to 'A'; Outlook Positive
Published:
August 23, 2024
by ENP Newswire
|
Patent Issued for Method and system for estimating an end of life of a rechargeable energy storage device (USPTO 12055595)
Published:
August 22, 2024
by Energy Business Daily
|
Pfizer is betting on next-gen cancer drugs to offset slowing demand for COVID vaccines
Published:
August 19, 2024
by Quartz
|
US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case
Published:
August 15, 2024
by FiercePharma
|
Ask us about our R&D/Patents market view